Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Improve antibiotic use to combat antibiotic resistance
  • Published Date:
    4/29/16
  • Language:
    English
Filetype[PDF-132.70 KB]


Details:
  • Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.)
  • Description:
    CDC is working to reduce unnecessary antibiotic use.

    White House National Action Plan to Combat Antibiotic-Resistant Bacteria (CARB) Goal: By 2020, reduce inappropriate outpatient antibiotic use by 50%.

    Poster illustration: Centers for Disease Control and Prevention (2012). Fleming-Dutra, K et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011. Journal of the American Medical Association. May 2016.

    CS265113-B

    Publication date from document properties.

    2016/16_265113-b_antibioresis_infographic_508.pdf

  • Subject:
  • Document Type:
    Poster
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : District of Columbia
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    12/21/17
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2017
    AR solutions In action
    Description:
    $2,651,352 Funding for AR Activities Fiscal Year 2017Funding to local health departments:$380,532 - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is critical to contain the spread of these infections. With 2016 funding, the District of ...
    File Type:
    Filetype[PDF - 568.28 KB]
  2. CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : Washington
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    12/22/17
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2017
    AR solutions In action
    Description:
    $9,553,153 Funding for AR Activities Fiscal Year 20171 local CDC fellowRegional Lab for the AR Lab Network (West)Funding to local health departments:$2,196,621 - AR LABORATORY NETWORK REGIONAL LABS boost state and local testing capacity and technolog...
    File Type:
    Filetype[PDF - 886.07 KB]
  3. CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : Georgia
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    12/21/17
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2017
    AR solutions In action
    Description:
    $6,555,608 Funding for AR Activities Fiscal Year 2017One of 10 sites for the Emerging Infections ProgramFunding to local health departments:$510,636 - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is critical to contain the spread of th...
    File Type:
    Filetype[PDF - 845.04 KB]
  4. CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : Ohio
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    12/21/17
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2017
    AR solutions In action
    Description:
    $1,851,476 Funding for AR Activities Fiscal Year 2017Funding to local health departments:$301,521 - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is critical to contain the spread of these infections. With 2016 funding, Ohio identified ...
    File Type:
    Filetype[PDF - 439.30 KB]
  5. CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : New Jersey
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    12/21/17
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2017
    AR solutions In action
    Description:
    $930,782 Funding for AR Activities Fiscal Year 2017Candida auris, a resistant fungus that can cause deadly infections, was identified in New Jersey. CDC provides resources to identify and contain resistant infections, like C. auris. After it emerged ...
    File Type:
    Filetype[PDF - 467.41 KB]